Exabis Library
Welcome to the e-CCO Library!
DOP065: Use of chromoendoscopy versus white light endoscopy for colorectal cancer surveillance in inflammatory bowel disease patients with primary sclerosing cholangitis; a six year experience
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
DOP066: Developing a core outcome set for fistulising perianal Crohn’s disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
DOP066: Disappearance of anti-drug antibodies to infliximab and adalimumab after addition of an immunomodulator in patients with inflammatory bowel disease
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
DOP066: Strict surveillance colonoscopy should be performed for the ulcerative colitis patients who underwent ileorectal anastomosis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
DOP067: Factors influencing infliximab and adalimumab antibody formation and 6 month retrospective follow-up in a tertiary IBD centre
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
DOP067: Risk of malignant and non-malignant complications of the rectal stump in patients with inflammatory bowel disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
DOP067: Treatment discontinuation, flares and hospitalisations among biologic-naïve patients with IBD over the first year of treatment: a comparative effectiveness study of vedolizumab vs. infliximab
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
DOP068: Crohn’s disease decision aid leads to more patients choosing combination therapy in a cluster randomised controlled trial
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
DOP068: Insufficient infliximab exposure predisposes to immunogenicity and enhanced clearance of infliximab in IBD
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
DOP068: The virtual electronic chromoendoscopy score in ulcerative colitis exhibits very good inter-rater agreement in scoring mucosal and vascular changes after computerised module training: a study across academic and community practice
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
DOP069: Dose optimisation using drug and antibody levels can benefit 50% patients prescribed anti-TNF therapy compared with empiric dose adjustment
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
DOP069: Improved quality of care and quality of life for IBD patients using mobile based remote monitoring platform: A randomised control trial
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
DOP069: Natural history of dysplasia and colorectal cancer in IBD patients in Belgium tertiary care centers
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
DOP06: Antibiotics as a risk factor for older onset IBD: A population-based cohort study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
DOP06: Deep characterization of IL-23 pathway in different gut segments and associated plasma biomarkers in inflammatory bowel disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
DOP06: Dynamic shifts in the balance of gut homing Treg and Th17 cells play a critical role in ulcerative colitis and may predict response to vedolizumab therapy
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
DOP06: Histologic activity in Ulcerative Colitis patients achieving endoscopic healing is associated with higher rate of relapse and a distinct mucosal microbial and transcriptional profile
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
DOP07 Long-term results of 4.5 years of faecal microbiota transplantation for treatment of refractory ulcerative colitis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
DOP070: Development and pilot of an index to identify young people with inflammatory bowel disease at risk of psychological morbidity
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
DOP070: Endoscopic response to induction therapy with TNF inhibitors is the best predictor of long term mucosal healing in Crohn's disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM